ReviewInternational journal of nanomedicine2026
Advances in Versatile Copper Sulfide-Based Nanoplatforms: From Synthesis and Properties to Multifaceted Biomedical Applications.
Review in International journal of nanomedicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Copper sulfide nanoparticles have become a versatile class of functional materials in the biomedical field. They exhibit responsiveness to near-infrared (NIR) light, catalytic activity, tunable electronic structures, and compatibility with integrated diagnostic and therapeutic designs. Controlled synthetic strategies have allowed copper sulfide nanomaterials to be precisely tailored with respect to their size, morphology, crystalline phase, and surface characteristics. Copper sulfide can serve as an imaging-active component, drug carrier, and bioresponsive modulator in composite biomedical nanoplatforms. This versatility has promoted the development of copper sulfide-based systems for tumor therapy, wound healing, biosensing, multimodal imaging, anti-inflammatory interventions and cardiovascular treatment. Copper sulfide has emerged as a promising platform for integrated therapeutic strategies. Copper sulfide-containing nanoplatforms can further support signal amplification and contrast enhancement in diagnostic applications. This review summarizes recent advances in the synthesis, properties and multifaceted biomedical applications of copper sulfide-bearing nanoplatforms. Special emphasis is placed on their contributions to composite fabrication, mechanism-driven design strategies, and application-oriented functional integration. We also discuss current challenges and future perspectives. Overall, copper sulfide-based nanoplatforms represent promising and adaptable systems for biomedicine.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.